Global Heparin Market Insights, Forecast to 2025

Global Heparin market size will increase to 1290 Million US$ by 2025, from 990 Million US$ in 2017, at a CAGR of 3.4% during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Heparin.

This report researches the worldwide Heparin market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions.

This study categorizes the global Heparin breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine

Heparin API is an anticoagulant (blood thinner) that prevents the formation of blood clots. With the accelerated pace of life and increasing aging population, global morbidity and mortality of cardiovascular and cerebrovascular disease are increased year by year. Heparin API is an efficient solution to those diseases. 

Raw materials of Heparin API are mainly porcine intestine, bovine lung and bovine intestine, etc. China pig slaughter amount accounted for more than 50% of the world. It has most abundant raw material resources all over the world.

The classification of Heparin includes Heparin Sodium, Heparin Calcium and others, and the proportion of Heparin Sodium in 2016 is about 88%, and the proportion is in decreasing trend from 2012 to 2016.

Heparin is widely used UFH and LMWH. The most proportion of Heparin is used in LMWH, and the proportion in 2016 is 88.9%

Europe is the largest consumption place, with a consumption market share nearly 40% in 2016. Following Europe, United Stated is the second largest consumption place with the consumption market share of 36%. 

Market competition is not intense. Hepalink, Bioibrica, Changshan Pharm, etc. are the leaders of the industry, with high-end customers; have been formed in the monopoly position in the industry. 

This report focuses on the top manufacturers' Heparin capacity, production, value, price and market share of Heparin in global market. The following manufacturers are covered in this report:
Hepalink
Changshan Pharm
Qianhong Bio-pharma
Opocrin
Pfizer
Aspen Oss
King-friend Biochemical Pharmaceutical
Bioibrica
Dongcheng Biochemicals
Jiulong Biochemicals
Tiandong
Xinbai
Yino Pharma Limited
Deebio

Heparin Breakdown Data by Type
Heparin Sodium
Heparin Calcium
Other

Heparin Breakdown Data by Application
UFH
LMWH

Heparin Production Breakdown Data by Region
United States
Europe
China
Japan
Other Regions

Heparin Consumption Breakdown Data by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa

The study objectives are:
To analyze and research the global Heparin capacity, production, value, consumption, status and forecast;
To focus on the key Heparin manufacturers and study the capacity, production, value, market share and development plans in next few years.
To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Heparin :
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Heparin Market, By Type

7.1.  Heparin Market, By Type, 2020-2028

7.1.1.    Low Molecular Weight Heparin

7.1.1.1.        Market Revenue and Forecast (2016-2028)

7.1.2.    Ultra-low Molecular Weight Heparin

7.1.2.1.        Market Revenue and Forecast (2016-2028)

7.1.3.    Unfractionated Heparin

7.1.3.1.        Market Revenue and Forecast (2016-2028)

Chapter 8.  Global Heparin Market, By Application

8.1.  Heparin Market, by Application, 2020-2028

8.1.1.    Venous Thromboembolism

8.1.1.1.        Market Revenue and Forecast (2016-2028)

8.1.2.    Atrial Fibrillation

8.1.2.1.        Market Revenue and Forecast (2016-2028)

8.1.3.    Renal Impairment

8.1.3.1.        Market Revenue and Forecast (2016-2028)

8.1.4.    Coronary Artery Disease

8.1.4.1.        Market Revenue and Forecast (2016-2028)

Chapter 9.  Global Heparin Market, By End User

9.1.  Heparin Market, by End User, 2020-2028

9.1.1.    Outpatient

9.1.1.1.        Market Revenue and Forecast (2016-2028)

9.1.2.    Inpatient

9.1.2.1.        Market Revenue and Forecast (2016-2028)

Chapter 10.      Global Heparin Market, By Route of Administration

10.1.        Heparin Market, By Route of Administration, 2020-2028

10.1.1.  Intravenous

10.1.1.1.      Market Revenue and Forecast (2016-2028)

10.1.2.  Subcutaneous

10.1.2.1.      Market Revenue and Forecast (2016-2028)

Chapter 11.      Global Heparin Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, By Type (2016-2028)

11.1.2.  Market Revenue and Forecast, by Application (2016-2028)

11.1.3.  Market Revenue and Forecast, by End User (2016-2028)

11.1.4.  Market Revenue and Forecast, By Route of Administration (2016-2028)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, By Type (2016-2028)

11.1.5.2.      Market Revenue and Forecast, by Application (2016-2028)

11.1.5.3.      Market Revenue and Forecast, by End User (2016-2028)

11.1.5.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, By Type (2016-2028)

11.1.6.2.      Market Revenue and Forecast, by Application (2016-2028)

11.1.6.3.      Market Revenue and Forecast, by End User (2016-2028)

11.1.6.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, By Type (2016-2028)

11.2.2.  Market Revenue and Forecast, by Application (2016-2028)

11.2.3.  Market Revenue and Forecast, by End User (2016-2028)

11.2.4.  Market Revenue and Forecast, By Route of Administration (2016-2028)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, By Type (2016-2028)

11.2.5.2.      Market Revenue and Forecast, by Application (2016-2028)

11.2.5.3.      Market Revenue and Forecast, by End User (2016-2028)

11.2.5.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, By Type (2016-2028)

11.2.6.2.      Market Revenue and Forecast, by Application (2016-2028)

11.2.6.3.      Market Revenue and Forecast, by End User (2016-2028)

11.2.6.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, By Type (2016-2028)

11.2.7.2.      Market Revenue and Forecast, by Application (2016-2028)

11.2.7.3.      Market Revenue and Forecast, by End User (2016-2028)

11.2.7.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, By Type (2016-2028)

11.2.8.2.      Market Revenue and Forecast, by Application (2016-2028)

11.2.8.3.      Market Revenue and Forecast, by End User (2016-2028)

11.2.8.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, By Type (2016-2028)

11.3.2.  Market Revenue and Forecast, by Application (2016-2028)

11.3.3.  Market Revenue and Forecast, by End User (2016-2028)

11.3.4.  Market Revenue and Forecast, By Route of Administration (2016-2028)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, By Type (2016-2028)

11.3.5.2.      Market Revenue and Forecast, by Application (2016-2028)

11.3.5.3.      Market Revenue and Forecast, by End User (2016-2028)

11.3.5.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, By Type (2016-2028)

11.3.6.2.      Market Revenue and Forecast, by Application (2016-2028)

11.3.6.3.      Market Revenue and Forecast, by End User (2016-2028)

11.3.6.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, By Type (2016-2028)

11.3.7.2.      Market Revenue and Forecast, by Application (2016-2028)

11.3.7.3.      Market Revenue and Forecast, by End User (2016-2028)

11.3.7.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, By Type (2016-2028)

11.3.8.2.      Market Revenue and Forecast, by Application (2016-2028)

11.3.8.3.      Market Revenue and Forecast, by End User (2016-2028)

11.3.8.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, By Type (2016-2028)

11.4.2.  Market Revenue and Forecast, by Application (2016-2028)

11.4.3.  Market Revenue and Forecast, by End User (2016-2028)

11.4.4.  Market Revenue and Forecast, By Route of Administration (2016-2028)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, By Type (2016-2028)

11.4.5.2.      Market Revenue and Forecast, by Application (2016-2028)

11.4.5.3.      Market Revenue and Forecast, by End User (2016-2028)

11.4.5.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, By Type (2016-2028)

11.4.6.2.      Market Revenue and Forecast, by Application (2016-2028)

11.4.6.3.      Market Revenue and Forecast, by End User (2016-2028)

11.4.6.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, By Type (2016-2028)

11.4.7.2.      Market Revenue and Forecast, by Application (2016-2028)

11.4.7.3.      Market Revenue and Forecast, by End User (2016-2028)

11.4.7.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, By Type (2016-2028)

11.4.8.2.      Market Revenue and Forecast, by Application (2016-2028)

11.4.8.3.      Market Revenue and Forecast, by End User (2016-2028)

11.4.8.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, By Type (2016-2028)

11.5.2.  Market Revenue and Forecast, by Application (2016-2028)

11.5.3.  Market Revenue and Forecast, by End User (2016-2028)

11.5.4.  Market Revenue and Forecast, By Route of Administration (2016-2028)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, By Type (2016-2028)

11.5.5.2.      Market Revenue and Forecast, by Application (2016-2028)

11.5.5.3.      Market Revenue and Forecast, by End User (2016-2028)

11.5.5.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, By Type (2016-2028)

11.5.6.2.      Market Revenue and Forecast, by Application (2016-2028)

11.5.6.3.      Market Revenue and Forecast, by End User (2016-2028)

11.5.6.4.      Market Revenue and Forecast, By Route of Administration (2016-2028)

Chapter 12.  Company Profiles

12.1.              GlaxoSmithKline plc

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Pfizer, Inc.

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Baxter

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Leo Pharma A/S

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Sanofi

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Dr. Reddy’s Laboratories Ltd.

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Aspen Holdings

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              B. Braun Medical Inc.

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Fresenius SE & Co. KGaA

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Teva Pharmaceutical Industries Ltd.

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers